Prevalence of Cryptosporidium Infection in Patients with Multiple Sclerosis Compared to Control Group in Isfahan City, Iran

Document Type : Original Article (s)

Authors

1 Associate Professor, Department of Mycology and Parasitology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Professor, Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Instructor, Department of Parasitology, School of Medicine, Isfahan University Medical Sciences, Isfahan, Iran

4 Student of Medicine, School of Medicine AND Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran

5 Student, Department of Laboratory Science, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: The aim of this study was to determine the prevalence of Cryptosporidium infection in patients with multiple sclerosis compared to control group in Isfahan city, Iran.Methods: In a case-control study, that was done in Alzahra hospital in Isfahan during 2015-2016, 50 multiple sclerotic and 50 healthy people were selected and the prevalence of Cryptosporidium in the two groups were detected by direct methods and concentration and compared between the two groups.Findings: Only 3 cases out of 100 were positive for Cryptosporidium SPP where one case was from control and 2 cases were from the case group (2 versus 4 percent). But, prevalence of Cryptosporidium in the two groups was not statistically different (P = 0.56). Prevalence of this parasite in residence and domestic animal keeping had significant difference. 3 cases of positive were in rural areas and kept domestic animals on their houses (P < 0.001).Conclusion: In this study, there was significant difference between this parasite and residence and keeping domestic animal.

Keywords


  1. Ness JM, Chabas D, Sadovnick AD, Pohl D, Banwell B, Weinstock-Guttman B. Clinical features of children and adolescents with multiple sclerosis. Neurology 2007; 68(16 Suppl 2): S37-S45.
  2. Ahlgren C, Lycke J, Oden A, Andersen O. High risk of MS in Iranian immigrants in Gothenburg, Sweden. Mult Scler 2010; 16(9): 1079-82.
  3. Solomon AJ, Whitham RH. Multiple sclerosis and vitamin D: a review and recommendations. Curr Neurol Neurosci Rep 2010; 10(5): 389-96.
  4. Handel AE, Giovannoni G, Ebers GC, Ramagopalan SV. Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol 2010; 6(3): 156-66.
  5. Ascherio A, Munger KL. Epstein-barr virus infection and multiple sclerosis: a review. J Neuroimmune Pharmacol 2010; 5(3): 271-7.
  6. Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010; 9(5): 520-32.
  7. Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F. Prevalence of multiple sclerosis in Isfahan, Iran. Neuroepidemiology 2006; 27(1): 39-44.
  8. Saadatnia M, Etemadifar M, Maghzi AH. Multiple sclerosis in Isfahan, Iran. Int Rev Neurobiol 2007; 79: 357-75.
  9. Hadley C. Should auld acquaintance be forgot. EMBO Rep 2004; 5(12): 1122-4.
  10. Strachan DP. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 2000; 55(Suppl 1): S2-10.
  11. Adisakwattana P, Saunders SP, Nel HJ, Fallon PG. Helminth-derived immunomodulatory molecules. Adv Exp Med Biol 2009; 666: 95-107.
  12. Cabada MM. Cryptosporidiosis differential diagnoses [Online]. [cited 2016 15 Aug]; Available from: URL: http://emedicine.medscape.com/article/215490-differential
  13. Dugdale DC 3rd, Vayas JM, Zieve D. Cryptosporidium enteritis [Online]. [cited 2006 Nov 3]. Available from: URL: http://www.healthcentral.com/encyclopedia/adam/cryptosporidium-enteritis-4009053/treatment/
  14. Pestehchian N, Etemadifarr M, Yousefi HA, Chiani M, Aslani N, Nasr Z. Frequency of Blood-tissue Parasitic Infections in Patients with Multiple Sclerosis, as Compared to their Family Members. Int J Prev Med 2014; 5(12): 1578-81.
  15. Osada Y, Kanazawa T. Parasitic helminths: new weapons against immunological disorders. J Biomed Biotechnol 2010; 2010: 743758.
  16. Everts B, Smits HH, Hokke CH, Yazdanbakhsh M. Helminths and dendritic cells: sensing and regulating via pattern recognition receptors, Th2 and Treg responses. Eur J Immunol 2010; 40(6): 1525-37.
  17. Goncalves ML, Araujo A, Ferreira LF. Human intestinal parasites in the past: new findings and a review. Mem Inst Oswaldo Cruz 2003; 98(Suppl 1): 103-18.
  18. Desoubeaux G, Caumont C, Passot C, Dartigeas C, Bailly E, Chandenier J, et al. Two cases of opportunistic parasite infections in patients receiving alemtuzumab. J Clin Pathol 2012; 65(1): 92-5.
  19. Moses H, Jr., Sriram S. An infectious basis for multiple sclerosis: perspectives on the role of Chlamydia pneumoniae and other agents. BioDrugs 2001; 15(3): 199-206.